Meldonium medicine. Metabolic therapy - myth or reality?

February 12, Jurmala hosts international conference "Metabolic Therapy - myth or reality." The conference came to the leading physicians and healthcare professionals.

The scientific program of the conference included presentations of practitioners as well as specialists of JSC «Grindeks», presented results of a clinical study on the effect of the original product Mildronate on the treatment of angina.

The conference program:
• P-FOX inhibitors in myocardial metabolism correction. Efficiency of Mildronate medicine experiment
• comorbid conditions. The main treatment approaches - whether there is a tablet from the most?
• The role of metabolic corrector in the treatment of cognitive impairment
• The impact of adoption on Mildronate adherence in patients with CHD
• Rationale for clinical studies on the efficacy and safety of Mildronate - MILSS II
• MILSS II study results